Navigation Links
Flextronics Announces Expansion of Medical Disposables Offering
Date:10/21/2009

SINGAPORE, Oct. 21 /PRNewswire-FirstCall/ -- Flextronics (Nasdaq: FLEX) is expanding its medical disposables offering and has signed an agreement to acquire Slomedical S.R.O through a share purchase agreement. Slomedical is a leading European manufacturer of disposable medical devices ranging from tubing sets to complex devices for minimally-invasive surgery. This deal is expected to close before the end of the calendar year, pending required regulatory clearances.

Upon completion, this strategic acquisition will expand Flextronics's overall capability for medical disposables through Slomedical's low cost European location in Slovakia and allow Flextronics to significantly advance its disposables strategy throughout Europe.

"We evaluated many companies to determine the best fit for the acquisition of our organization. Flextronics is the ideal organization based on its ability to augment our current capabilities and its significant market strength in the medical space," said Frank Sodha, managing director, Slomedical. "We have grown to a point that in order to expand and support the growing needs of our customers, we must partner with a larger organization such as Flextronics. We are all very excited and look forward to working with the team."

In addition to today's announced planned acquisition of Slomedical, Flextronics recently completed a major expansion of its Tijuana, Mexico campus which is dedicated to disposable medical device manufacturing. Flextronics's Tijuana campus now includes key vertical integration capabilities of plastic injection molding and plastic extrusion as well as world class clean room assembly operations. With the addition of these capabilities at its Tijuana Medical campus, Flextronics is able to drive value for its customers through lower costs and faster time-to-market.

"The major expansion of our Tijuana, Mexico campus and the imminent acquisition of Slomedical will significantly expand our ability to serve the global disposables medical device market for European and multi-national customers," said Dan Croteau, president, Flextronics Medical. "Upon completion of the deal, we look forward to expanding Slomedical's well established low-cost operations and investing in additional manufacturing capabilities, quality systems and design services to deliver more value, lower costs and faster time-to-market to our customers. On behalf of the Flextronics team, we look forward to working with the Slomedical team to continue to grow our businesses together."

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer, industrial, infrastructure, medical and mobile OEMs. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 30 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit www.flextronics.com.

SOURCE Flextronics


'/>"/>
SOURCE Flextronics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):